Syndax Pharmaceuticals (Germany) Analysis
| 1T3 Stock | EUR 13.60 0.20 1.49% |
Syndax Pharmaceuticals is overvalued with Real Value of 11.15 and Hype Value of 13.6. The main objective of Syndax Pharmaceuticals stock analysis is to determine its intrinsic value, which is an estimate of what Syndax Pharmaceuticals is worth, separate from its market price. There are two main types of Syndax Pharmaceuticals' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Syndax Pharmaceuticals' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Syndax Pharmaceuticals' stock to identify patterns and trends that may indicate its future price movements.
The Syndax Pharmaceuticals stock is traded in Germany on Frankfurt Exchange, with the market opening at 08:00:00 and closing at 22:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Germany. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Syndax Pharmaceuticals' ongoing operational relationships across important fundamental and technical indicators.
Syndax |
Syndax Stock Analysis Notes
About 96.0% of the company shares are owned by institutions such as pension funds. The book value of Syndax Pharmaceuticals was presently reported as 5.62. The company had not issued any dividends in recent years. Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. The company was founded in 2005 and is headquartered in Waltham, Massachusetts. Syndax Pharmaceuticals operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 38 people. For more info on Syndax Pharmaceuticals please contact Michael MBA at 781 419 1400 or go to https://www.syndax.com.Syndax Pharmaceuticals Investment Alerts
| Syndax Pharmaceuticals generated a negative expected return over the last 90 days | |
| Syndax Pharmaceuticals has high historical volatility and very poor performance | |
| Over 96.0% of the company shares are owned by institutions such as pension funds |
Syndax Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.67 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Syndax Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Syndax Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Syndax Profitablity
Syndax Pharmaceuticals' profitability indicators refer to fundamental financial ratios that showcase Syndax Pharmaceuticals' ability to generate income relative to its revenue or operating costs. If, let's say, Syndax Pharmaceuticals is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Syndax Pharmaceuticals' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Syndax Pharmaceuticals' profitability requires more research than a typical breakdown of Syndax Pharmaceuticals' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.11) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.11) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.11. Technical Drivers
As of the 5th of February, Syndax Pharmaceuticals has the Coefficient Of Variation of (1,971), risk adjusted performance of (0.03), and Variance of 20.64. Syndax Pharmaceuticals technical analysis provides you with a way to harness past market data to determine a pattern that measures the direction of the company's future prices. Please validate Syndax Pharmaceuticals variance, treynor ratio, and the relationship between the standard deviation and information ratio to decide if Syndax Pharmaceuticals is priced more or less accurately, providing market reflects its prevalent price of 13.6 per share.Syndax Pharmaceuticals Price Movement Analysis
The output start index for this execution was twenty-nine with a total number of output elements of thirty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Syndax Pharmaceuticals middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Syndax Pharmaceuticals. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Syndax Pharmaceuticals Outstanding Bonds
Syndax Pharmaceuticals issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Syndax Pharmaceuticals uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Syndax bonds can be classified according to their maturity, which is the date when Syndax Pharmaceuticals has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| SNV 5625 15 FEB 28 Corp BondUS87164DVJ61 | View | |
| SYNCHRONY FINL 45 Corp BondUS87165BAG86 | View | |
| SYNCHRONY FINL 395 Corp BondUS87165BAM54 | View | |
| SYNCHRONY FINL 37 Corp BondUS87165BAL71 | View | |
| SYF 4875 13 JUN 25 Corp BondUS87165BAS25 | View |
Syndax Pharmaceuticals Predictive Daily Indicators
Syndax Pharmaceuticals intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Syndax Pharmaceuticals stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.01 | |||
| Day Median Price | 13.6 | |||
| Day Typical Price | 13.6 | |||
| Price Action Indicator | 0.1 | |||
| Period Momentum Indicator | 0.2 |
Syndax Pharmaceuticals Forecast Models
Syndax Pharmaceuticals' time-series forecasting models are one of many Syndax Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Syndax Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Syndax Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Syndax Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Syndax shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Syndax Pharmaceuticals. By using and applying Syndax Stock analysis, traders can create a robust methodology for identifying Syndax entry and exit points for their positions.
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. The company was founded in 2005 and is headquartered in Waltham, Massachusetts. Syndax Pharmaceuticals operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 38 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Syndax Pharmaceuticals to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Crypto Correlations Now
Crypto CorrelationsUse cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |
| All Next | Launch Module |
Complementary Tools for Syndax Stock analysis
When running Syndax Pharmaceuticals' price analysis, check to measure Syndax Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Syndax Pharmaceuticals is operating at the current time. Most of Syndax Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Syndax Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Syndax Pharmaceuticals' price. Additionally, you may evaluate how the addition of Syndax Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Transaction History View history of all your transactions and understand their impact on performance |